Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand
新西兰在特殊授权下,为2型糖尿病患者启动新近获得资助的恩格列净和度拉糖肽治疗的真实世界案例
期刊:BMC Health Services Research
影响因子:
doi:10.1186/s12913-025-12601-3
Chepulis, Lynne; Rodrigues, Mark; Gan, Han; Keenan, Rawiri; Kenealy, Tim; Murphy, Rinki; Karu, Leanne Te; Scott-Jones, Jo; Clark, Penny; Moffitt, Allan; Mustafa, Sara; Lawrenson, Ross; Paul, Ryan